BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/25/2025 6:55:46 AM | Browse: 13 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 108470
Country China
Category Medicine, Research & Experimental
Manuscript Type Retrospective Cohort Study
Article Title Efficacy of adjuvant chemotherapy in stage II colon cancer patients with twelve or more lymph nodes retrieve
Manuscript Source Unsolicited Manuscript
All Author List Yu Huo, Yue-Yang Zhang, Shuai Jiao, Zhong-Yuan Bai, Wen-Qi Bai, Hai-Tao Zhou and Xu Guan
Funding Agency and Grant Number
Funding Agency Grant Number
Shanxi Special Projects of the Central Government Guiding Local Science and Technology Development of China YDZJSX2021B016
Shanxi Cancer Hospital Doctoral Master's Guide and Companion Flying Fund SD2023010
Corresponding Author Wen-Qi Bai, Department of General Surgery Sciences, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, No. 3 Xinghualing District Workers’ New Village, Taiyuan 030000, Shanxi Province, China. baiwenqi1998@163.com
Key Words Stage II; Colon cancer; Lymph nodes; Chemotherapy; Prognosis
Core Tip No adjuvant chemotherapy (ACT) continues to be a significant independent predictor for patients with stage II colon cancer who have 12 or more lymph nodes (LNs) removed. Even among these patients with T3 stage and grade 1/2, ACT still leads to improved prognosis. Based on two large-scale population-based cohorts and the propensity score matching method, we validated the generalizability and reliability of these findings. This research confirms that patients with adequate LNs retrieval (≥ 12 LNs) can still benefit from ACT, which is expected to provide valuable insights and further guide clinical practice in the management of colorectal carcinoma.
Citation Huo Y, Zhang YY, Jiao S, Bai ZY, Bai WQ, Zhou HT, Guan X. Efficacy of adjuvant chemotherapy in stage II colon cancer patients with twelve or more lymph nodes retrieve. World J Gastrointest Oncol 2025; In press
Received
2025-04-15 11:12
Peer-Review Started
2025-04-15 11:12
To Make the First Decision
Return for Revision
2025-05-15 12:00
Revised
2025-05-26 10:31
Second Decision
2025-07-25 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-07-25 06:55
Articles in Press
2025-07-25 06:55
Publication Fee Transferred
2025-05-28 10:33
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com